Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Assets

Fiscal Quarter	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Cash & Equivalents	16.99	30.79	47.37	62.79	48.99	67.13	74.72	84.25	102.92	119.17	126.56	37.61	9.62	16.64	25.04	35.29	51.99	68.14	83.7	93.63
Short-Term Investments	14.74	14.61	14.4	14.39	14.2	13.35	13.85	13.33	5.45	-	-	-	-	-	-	-	-	-	-	-
Cash & Short-Term Investments	31.73	45.4	61.77	77.18	63.18	80.48	88.56	97.58	108.36	119.17	126.56	37.61	9.62	16.64	25.04	35.29	51.99	68.14	83.7	93.63
Cash Growth (YoY)	-49.78%	-43.59%	-30.25%	-20.91%	-41.70%	-32.46%	-30.03%	159.46%	1026.18%	616.23%	405.48%	6.58%	-81.49%	-75.58%	-70.09%	-62.31%	-46.83%	-33.92%	-19.77%	507.99%
Other Receivables	-	-	-	-	-	-	-	-	-	-	-	-	0.48	-	0.15	0.15	0.68	0.34	-	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	0.48	-	0.15	0.15	0.68	0.34	-	-
Prepaid Expenses	2.58	1.54	1.48	1.76	3.54	1.59	1.38	2.37	2.47	1.51	1.48	1.39	1.04	0.8	0.46	0.88	1.13	0.2	0.25	0.36
Other Current Assets	-	-	-	-	-	-	-	-	-	-	0.07	0.07	0.43	0.07	0.41	0.59	1.2	2.33	2.82	2.45
Total Current Assets	34.31	46.94	63.25	78.93	66.72	82.08	89.94	99.95	110.84	120.67	128.11	39.08	11.58	17.51	26.06	36.91	54.99	71	86.77	96.44
Property, Plant & Equipment	1.03	1.23	1.42	1.59	1.74	1.81	1.89	2.05	2.19	2.26	2.38	2.49	2.63	2.77	2.9	3.02	3.13	3.08	3.21	3.53
Long-Term Deferred Charges	0.04	0.06	-	-	-	0.13	-	-	-	-	0.47	0.53	0.72	0.71	0.65	0.66	0.5	0.47	0.46	0.49
Other Long-Term Assets	0.36	0.34	0.39	0.41	0.47	0.32	0.48	0.5	0.52	0.73	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.05
Total Assets	35.74	48.56	65.06	80.93	68.92	84.34	92.31	102.5	113.55	123.65	131.07	42.2	15.03	21.09	29.71	40.7	58.73	74.64	90.54	100.5

Liabilities

Fiscal Quarter	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Accounts Payable	1	1.54	1.28	1.83	0.49	0.65	1.04	0.72	1.21	1.55	1.74	1.31	1.62	2.47	1.6	2.96	5.47	2.76	1.95	2.66
Accrued Expenses	9.24	8.76	9.25	8.42	6.58	8.81	5.47	3.82	2.16	2.24	0.13	0.29	0.42	0.8	1.09	1.19	0.73	1.33	2.63	3.43
Short-Term Debt	-	0.1	0.38	0.66	0.93	-	-	-	-	-	-	-	0.78	0.11	0.42	0.73	1.04	-	-	-
Current Portion of Leases	0.72	0.7	0.62	0.6	0.64	0.56	0.6	0.53	0.57	0.55	0.54	0.52	0.5	0.49	0.47	0.46	0.44	0.43	0.42	0.4
Current Unearned Revenue	0.23	1.71	2	2.14	2.51	2.59	2.51	2.47	2.3	0.79	1.76	0.79	0.71	0.71	0.71	0.71	1.24	1.24	1.42	1.42
Total Current Liabilities	11.19	12.8	13.53	13.64	11.16	12.61	9.62	7.52	6.24	5.12	4.16	2.91	4.05	4.57	4.29	6.05	8.93	5.77	6.42	7.91
Long-Term Leases	0.06	0.25	0.43	0.61	0.78	0.95	1.11	1.27	1.42	1.57	1.72	1.86	2	2.12	2.25	2.38	2.5	2.61	2.72	3.14
Long-Term Unearned Revenue	-	-	0.18	0.34	0.22	0.39	0.45	0.73	1.09	2.67	1.9	1.78	2.14	2.32	2.49	2.67	1.25	1.56	1.42	1.78
Total Liabilities	11.26	13.04	14.14	14.59	12.16	13.95	11.19	9.52	8.75	9.37	7.78	6.55	8.18	9.01	9.03	11.1	12.67	9.93	10.56	12.83

Shareholders' Equity

Fiscal Quarter	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Common Stock	0.04	0.04	0.04	0.04	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.01	0.01	0.01	0.21	0.21	0.21	0.01	0.21	0.2
Additional Paid-In Capital	518.76	516.77	515.88	512.4	483.43	481.96	479.05	476.8	475.69	474.44	473.92	379.94	344.56	342.89	339.06	338.23	337.19	336.28	334.66	324.81
Retained Earnings	-490.35	-477.32	-461.04	-442.14	-422.73	-407.63	-394	-379.91	-366.95	-356.21	-346.69	-340.34	-333.75	-326.85	-314.62	-304.86	-287.38	-267.6	-250.92	-240.38
Treasury Stock	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97
Comprehensive Income & Other	-0.01	-0	0.01	0.01	0	0.01	0.01	0.02	0	-	-	-	-	-	-	-	-	-	-	-
Total Common Equity	24.48	35.52	50.92	66.34	56.77	70.39	81.12	92.97	104.8	114.29	123.28	35.65	6.85	12.08	20.67	29.61	46.05	64.72	79.98	80.66
Shareholders' Equity	24.48	35.52	50.92	66.34	56.77	70.39	81.12	92.97	104.8	114.29	123.28	35.65	6.85	12.08	20.67	29.61	46.05	64.72	79.98	87.67
Total Liabilities & Equity	35.74	48.56	65.06	80.93	68.92	84.34	92.31	102.5	113.55	123.65	131.07	42.2	15.03	21.09	29.71	40.7	58.73	74.64	90.54	100.5

Additional Metrics

Fiscal Quarter	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Total Debt	0.78	1.04	1.43	1.87	2.36	1.51	1.71	1.79	1.99	2.12	2.25	2.38	3.28	2.71	3.15	3.57	3.98	3.04	3.14	3.54
Net Cash (Debt)	30.95	44.36	60.34	75.31	60.82	78.97	86.85	95.78	106.37	117.05	124.3	35.23	6.34	13.93	21.89	31.72	48	65.1	80.56	90.08
Net Cash Growth (YoY)	-49.12%	-43.83%	-30.52%	-21.38%	-42.82%	-32.53%	-30.13%	171.89%	1578.30%	740.43%	467.82%	11.06%	-86.80%	-78.61%	-72.82%	-64.79%	-49.01%	-34.50%	-19.79%	713.38%
Net Cash Per Share	0.72	1.05	1.43	2.11	1.90	2.50	2.83	3.13	3.48	3.83	4.23	3.51	0.86	1.95	3.18	4.60	6.97	9.46	11.94	13.99
Filing Date Shares Outstanding	44.38	41.03	39.62	39.5	30.68	29.16	28.86	27.84	27.06	27.03	27.03	27.02	9.36	7.87	7.31	6.89	6.89	6.89	6.88	6.66
Total Common Shares Outstanding	44.38	39.62	39.62	38.89	29.28	29	28.32	27.06	27.06	27.03	27.03	12.01	7.88	7.31	6.9	6.89	6.89	6.88	6.88	6.55
Working Capital	23.12	34.15	49.72	65.29	55.56	69.46	80.32	92.43	104.6	115.55	123.95	36.17	7.53	12.93	21.77	30.87	46.07	65.23	80.35	88.53
Book Value Per Share	0.55	0.90	1.29	1.71	1.94	2.43	2.86	3.44	3.87	4.23	4.56	2.97	0.87	1.65	3.00	4.29	6.68	9.40	11.62	12.32
Tangible Book Value	24.48	35.52	50.92	66.34	56.77	70.39	81.12	92.97	104.8	114.29	123.28	35.65	6.85	12.08	20.67	29.61	46.05	64.72	79.98	80.66
Tangible Book Value Per Share	0.55	0.90	1.29	1.71	1.94	2.43	2.86	3.44	3.87	4.23	4.56	2.97	0.87	1.65	3.00	4.29	6.68	9.40	11.62	12.32
Machinery	-	1.12	-	-	-	1.6	-	-	-	1.48	-	-	1.48	1.49	1.67	1.65	1.63	1.45	1.47	1.48
Construction In Progress	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.02
Leasehold Improvements	-	0.19	-	-	-	0.22	-	-	-	0.21	-	-	0.21	0.21	0.21	0.21	0.21	0.21	0.21	0.21

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error